These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 18975380)
1. NDRG3 is an androgen regulated and prostate enriched gene that promotes in vitro and in vivo prostate cancer cell growth. Wang W; Li Y; Li Y; Hong A; Wang J; Lin B; Li R Int J Cancer; 2009 Feb; 124(3):521-30. PubMed ID: 18975380 [TBL] [Abstract][Full Text] [Related]
2. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells. Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer. Gui SL; Teng LC; Wang SQ; Liu S; Lin YL; Zhao XL; Liu L; Sui HY; Yang Y; Liang LC; Wang ML; Li XY; Cao Y; Li FY; Wang WQ Int Urol Nephrol; 2016 May; 48(5):701-9. PubMed ID: 26837773 [TBL] [Abstract][Full Text] [Related]
4. High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways. Qi Y; Zhao W; Li M; Shao M; Wang J; Sui H; Yu H; Shao W; Gui S; Li J; Jia X; Jiang D; Li Y; Zhang P; Wang S; Wang W Int J Oncol; 2018 Jul; 53(1):358-370. PubMed ID: 29749439 [TBL] [Abstract][Full Text] [Related]
5. Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. Juang HH; Chung LC; Sung HC; Feng TH; Lee YH; Chang PL; Tsui KH Prostate; 2013 Oct; 73(14):1495-506. PubMed ID: 23794209 [TBL] [Abstract][Full Text] [Related]
6. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells. Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946 [TBL] [Abstract][Full Text] [Related]
7. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
8. Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion. Xin H; Cao Y; Shao ML; Zhang W; Zhang CB; Wang JT; Liang LC; Shao WW; Qi YL; Li Y; Zhang ZY; Yang Z; Sun YH; Zhang PX; Jia LL; Wang WQ Int Urol Nephrol; 2018 May; 50(5):861-868. PubMed ID: 29524043 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome. Huang M; Narita S; Tsuchiya N; Ma Z; Numakura K; Obara T; Tsuruta H; Saito M; Inoue T; Horikawa Y; Satoh S; Habuchi T Carcinogenesis; 2011 Nov; 32(11):1589-96. PubMed ID: 21828059 [TBL] [Abstract][Full Text] [Related]
11. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
12. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells. Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505 [TBL] [Abstract][Full Text] [Related]
13. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359 [TBL] [Abstract][Full Text] [Related]
14. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells. Gueron G; De Siervi A; Ferrando M; Salierno M; De Luca P; Elguero B; Meiss R; Navone N; Vazquez ES Mol Cancer Res; 2009 Nov; 7(11):1745-55. PubMed ID: 19903769 [TBL] [Abstract][Full Text] [Related]
15. miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3. Fan CG; Wang CM; Tian C; Wang Y; Li L; Sun WS; Li RF; Liu YG Oncol Rep; 2011 Nov; 26(5):1281-6. PubMed ID: 21725618 [TBL] [Abstract][Full Text] [Related]
16. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938 [TBL] [Abstract][Full Text] [Related]
17. The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Thobe MN; Gurusamy D; Pathrose P; Waltz SE Oncogene; 2010 Jan; 29(2):214-26. PubMed ID: 19838218 [TBL] [Abstract][Full Text] [Related]
18. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer. Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505 [TBL] [Abstract][Full Text] [Related]
19. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase. Igawa T; Lin FF; Rao P; Lin MF Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404 [TBL] [Abstract][Full Text] [Related]
20. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]